Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Gustav Belz
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Concepts & Ideas
Chemicals & Drugs
Physiology
Anatomy
Sign-in to see full Profile
Network (preview)
13
Butzer, Raunhild
12
Breithaupt-Grögler, K
6
Mutschler, Ernst
4
Malerczyk, C
3
Herrmann, V
3
Roll, S
3
Fuchs, B
2
Kober, Susan
2
Loew, Dieter
1
Mohr-Kahaly, Susanne
1
Schug, Barbara
1
Spahn-Langguth, Hilde
1
Wurst, Wilhelm
1
Hermann, Robert
1
Gaus, Wilhelm
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Gustav Belz (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2003: Belz Gustav G
Angiotensin II dose-effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology.
British journal of clinical pharmacology 2003;56(1):3-10.
-
2003: Belz Gustav Georg; Loew Dieter
Dose-response related efficacy in orthostatic hypotension of a fixed combination of D-camphor and an extract from fresh crataegus berries and the contribution of the single components.
Phytomedicine : international journal of phytotherapy and phytopharmacology 2003;10 Suppl 4():61-7.
-
2002: Belz G G; Butzer R; Gaus W; Loew D
Camphor-Crataegus berry extract combination dose-dependently reduces tilt induced fall in blood pressure in orthostatic hypotension.
Phytomedicine : international journal of phytotherapy and phytopharmacology 2002;9(7):581-8.
-
2002: Belz Gustav G; Butzer Raunhild; Kober Susan; Mutschler Ernst
Pharmacodynamic studies on the angiotensin II type 1 antagonists irbesartan and candesartan based on angiotensin II dose response in humans.
Journal of cardiovascular pharmacology 2002;39(4):561-8.
-
2001: Breithaupt-Grögler K; Ungethüm W; Meurer-Witt B; Belz G G
Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.
European journal of clinical pharmacology 2001;57(4):275-84.
-
2001: Belz G G; Breithaupt-Grögler K; Osowski U
Treatment of congestive heart failure--current status of use of digitoxin.
European journal of clinical investigation 2001;31 Suppl 2():10-7.
-
2000: Belz G G; Breithaupt-Grögler K; Butzer R; Fuchs W; Hausdorf C; Mang C
The pharmacological potency of various AT(1) antagonists assessed by Schild regression technique in man.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2000;1(4):336-41.
-
2000: Fuchs B; Breithaupt-Grögler K; Belz G G; Roll S; Malerczyk C; Herrmann V; Spahn-Langguth H; Mutschler E
Comparative pharmacodynamics and pharmacokinetics of candesartan and losartan in man.
The Journal of pharmacy and pharmacology 2000;52(9):1075-83.
-
1999: Belz G G; Butzer R; Kober S; Mang C; Mutschler E
Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay.
Clinical pharmacology and therapeutics 1999;66(4):367-73.
-
1999: Breithaupt-Grögler K; Belz G G
Epidemiology of the arterial stiffness.
Pathologie-biologie 1999;47(6):604-13.
-
1999: Breithaupt-Grögler K; Niebch G; Schneider E; Erb K; Hermann R; Blume H H; Schug B S; Belz G G
Dose-proportionality of oral thioctic acid--coincidence of assessments via pooled plasma and individual data.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1999;8(1):57-65.
-
1998: Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz G G
Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
International journal of clinical pharmacology and therapeutics 1998;36(8):425-31.
-
1998: Malerczyk C; Fuchs B; Belz G G; Roll S; Butzer R; Breithaupt-Grögler K; Herrmann V; Magin S G; Högemann A; Voith B; Mutschler E
Angiotensin II antagonism and plasma radioreceptor-kinetics of candesartan in man.
British journal of clinical pharmacology 1998;45(6):567-73.
-
1997: Breithaupt-Grögler K; Ling M; Boudoulas H; Belz G G
Protective effect of chronic garlic intake on elastic properties of aorta in the elderly.
Circulation 1997;96(8):2649-55.
-
1997: Breithaupt-Grögler K; Malerczyk C; Belz G G; Butzer R; Herrmann V; Stass H; Wensing G
Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man.
International journal of clinical pharmacology and therapeutics 1997;35(10):434-41.
-
1997: Belz G G; Fuchs B; Malerczyk C; Magin S G; Roll S; Mutschler E
Inhibition of angiotensin II pressor response and ex vivo angiotensin II radioligand binding by candesartan cilexetil and losartan in healthy human volunteers.
Journal of human hypertension 1997;11 Suppl 2():S45-7.
-
1997: Nixdorff U; de Mey C; Belz G G; Erbel R; Simon H; Butzer R; Schroeter V; Meyer J
Beta-adrenergic stimulation enhances left ventricular diastolic performance in normal subjects.
Journal of cardiovascular pharmacology 1997;29(4):476-84.
-
1996: De Mey C; Erb K; Schroeter V; Belz G G
Differentiation of inodilatory responses by non-invasive measures of cardiovascular performance in healthy man.
International journal of clinical pharmacology and therapeutics 1996;34(12):525-32.
-
1996: Breithaupt-Grögler K; Leschinger M; Belz G G; Butzer R; Erb K; de May C; Sinn W
Influence of antihypertensive therapy with cilazapril and hydrochlorothiazide on the stiffness of the aorta.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1996;10(1):49-57.
-
1996: Goldberg M R; de Mey C; Wroblewski J M; Li Q; Schroeter V; Belz G G
Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
Clinical pharmacology and therapeutics 1996;59(1):72-82.
-
1995: De Mey C; Schroeter V; Butzer R; Roll S; Belz G G
Method specificity of non-invasive blood pressure measurement: oscillometry and finger pulse pressure vs acoustic methods.
British journal of clinical pharmacology 1995;40(4):291-7.
-
1995: Belz G G
Elastic properties and Windkessel function of the human aorta.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1995;9(1):73-83.
-
1995: de Mey C; Erb K; Zimmermann T; Mutschler H; Blume H; Belz G G
Clinical pharmacological equivalence of a novel FCH-free GTN spray with low ethanol content vs a FCH-containing GTN spray.
European journal of clinical pharmacology 1995;47(5):437-43.
-
1994: De Mey C; Breithaupt-Grögler K; Schloos J; Palm D; Belz G G
Reproducibility and consistency of the responses to supine bicycle ergometry; evaluation in conjunction with beta 1-adrenoceptor occupancies.
British journal of clinical pharmacology 1994;38(5):480-3.
-
1994: Erb K; de Mey C; Zimmermann T; Mutschler H; Roll S; Belz G G
[Pharmacodynamic equivalence and clinical trial of a new fluorocarbon-free glycerol trinitrate pump spray with low ethanol content in comparison to a fluorocarbon-containing reference spray and a fluorocarbon-free pump spray with high ethanol content]
Arzneimittel-Forschung 1994;44(4):478-82.
-
1994: de Mey C; Breithaupt K; Schloos J; Neugebauer G; Palm D; Belz G G
Dose-effect and pharmacokinetic-pharmacodynamic relationships of the beta 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humans.
Clinical pharmacology and therapeutics 1994;55(3):329-37.
-
1994: de Mey C; Breithaupt K; Seibert-Grafe M; Belz G G
Differential effects of the novel NO-donating drug pirsidomine and isosorbide dinitrate on the venous vascular bed.
European journal of clinical pharmacology 1994;46(4):295-9.
-
1994: Belz G G; Breithaupt K; Erb K
Review of studies on the clinical pharmacodynamics of cilazapril.
Journal of cardiovascular pharmacology 1994;24 Suppl 2():S14-9.
-
1993: Kleinbloesem C H; Weber C; Fahrner E; Dellenbach M; Welker H; Schröter V; Belz G G
Hemodynamics, biochemical effects, and pharmacokinetics of the renin inhibitor remikiren in healthy human subjects.
Clinical pharmacology and therapeutics 1993;53(5):585-92.
-
1993: de Mey C; Beithaupt K; Palm D; Fuhr U; Belz G G
Effect of pretreatment with the selective beta 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and beta-adrenoceptor subtype specific occupancy of celiprolol in healthy man.
European journal of clinical pharmacology 1993;44(4):341-8.
-
1993: Li Q; Belz G G
Systolic time intervals in clinical pharmacology.
European journal of clinical pharmacology 1993;44(5):415-21.
-
1992: de Mey C; Belz G G; Nixdorf U; Butzer R; Schroeter V; Meyer J; Erbel R
Relative sensitivity of four noninvasive methods in assessing systolic cardiovascular effects of isoproterenol in healthy volunteers.
Clinical pharmacology and therapeutics 1992;52(6):609-19.
-
1992: Belz G G; Breithaupt K; de Mey C
Cholinergic system, heart rate, and blood pressure.
Blood pressure 1992;1(4):260.
-
1992: Breithaupt K; de Mey C; Belz G G
Noninvasive methods to assess vascular drug effects in humans.
International journal of clinical pharmacology, therapy, and toxicology 1992;30(11):442-4.
-
1992: Breithaupt K; Leschinger M; de Mey C; Belz G G
Aortic compliance in hypertension--effects of cilazapril and hydrochlorothiazide can be distinguished.
Blood pressure 1992;1(3):187.
-
1992: Schmitt R; Kleinbloesem C H; Belz G G; Schroeter V; Feifel U; Pozenel H; Kirch W; Halabi A; Woittiez A J; Welker H A
Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertension.
Clinical pharmacology and therapeutics 1992;52(3):314-23.
-
1992: Belz G G; De Mey C
A case for sublingual captopril.
Blood pressure 1992;1(2):120-2.
-
1992: Belz G G; Bliesath H; Essig J; Neumann N; Zech K; Wurst W
Differential effects of two dihydropyridine calcium antagonists in humans.
Clinical pharmacology and therapeutics 1992;52(1):68-79.
-
1992: de Mey C; Matthews J; Butzer R; Schroeter V; Belz G G
Agreement and reproducibility of the estimates of cardiovascular function by impedance cardiography and M-mode echocardiography in healthy subjects.
British journal of clinical pharmacology 1992;34(1):88-92.
-
1992: de Mey C; Elich D; Schroeter V; Butzer R; Belz G G
Captopril does not interact with the pharmacodynamics and pharmacokinetics of digitoxin in healthy man.
European journal of clinical pharmacology 1992;43(4):445-7.
-
1992: Beermann C; Schloos J; Belz G G
Constriction of human dorsal hand veins in vivo with several vasoconstrictors and the influence of oral administration of carvedilol.
Journal of cardiovascular pharmacology 1992;19 Suppl 1():S12-7.
-
1992: Beermann C; Schloos J; Belz G G
Oral administration of carvedilol and prazosin inhibits the prostaglandin F2 alpha- and noradrenaline-induced contraction of human hand veins in vivo.
The Clinical investigator 1992;70 Suppl 1():S13-9.
-
1992: Belz G G; Beermann C
Venodilatory effects of nicorandil in healthy volunteers.
Journal of cardiovascular pharmacology 1992;20 Suppl 3():S57-8.
-
1991: Erb K A; de Mey C; Wolf G K; Kroll M; Belz G G
[Evaluation of pharmacodynamic equivalence of glycerol trinitrate-containing sprays for oral administration with or without chlorofluorocarbons ]
Arzneimittel-Forschung 1991;41(5):484-8.
-
1991: Dietz U; Belz G G
Low frequency arterial wall movements for indirect blood pressure measurement in man. Validation of a method for non-invasive assessment of blood pressure under the influence of isoprenaline and angiotensin.
Arzneimittel-Forschung 1991;41(5):557-62.
-
1991: Breithaupt K; Belz G G; Kempinski S; Schicketanz K H; Dieterich H A
[Effect of oral administration of enoximone on cardiac performance, arterial circulation at rest and on the vasoconstrictor effect of local noradrenaline infusions into the human hand vein]
Zeitschrift für Kardiologie 1991;80 Suppl 4():15-20.
-
1991: Erb K A; Essig J; Breithaupt K; Belz G G
Clinical pharmacodynamic studies with cilazapril and a combination of cilazapril and propranolol.
Drugs 1991;41 Suppl 1():11-7.
-
1991: Palm D; Wellstein A; Schloos J; Belz G G
[Correlation between pharmacokinetics and dynamics: explanation of clinical aspects exemplified by beta-receptor blockers]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1991;97():338-42.
-
1990: Breithaupt K; Belz G G; Kempinski S; Schicketanz K H; Dieterich H A
The effects of oral enoximone on cardiac performance, calf arterial blood flow, and constrictor effects of norepinephrine infused into hand veins in humans.
Journal of cardiovascular pharmacology 1990;16(3):349-53.
-
1990: Erb K A; Breithaupt K; Belz G G
Beta-blockers and ACE-inhibitors--further evidence for therapeutic benefit of this combination in hypertension.
Journal of human hypertension 1990;4(1):63.
-
1989: Belz G G; Beermann C; Schloos J; Kleinbloesem C H
The effect of oral cilazapril and prazosin on the constrictor effects of locally infused angiotensin I and noradrenaline in human dorsal hand veins.
British journal of clinical pharmacology 1989;28(5):608-11.
-
1989: Belz G G; Breithaupt K; Erb K; Kleinbloesem C H; Wolf G K
Influence of the angiotensin converting enzyme inhibitor cilazapril, the beta-blocker propranolol and their combination on haemodynamics in hypertension.
Journal of hypertension 1989;7(10):817-24.
-
1989: Mohr-Kahaly S; Epperlein S; Erbel R; Darius H; Belz G G; Meyer J
[Influence of angiotensin-induced change in afterload on hemodynamics in mitral valve insufficiency. A 2-dimensional and color-coded Doppler echocardiography study]
Zeitschrift für Kardiologie 1989;78(6):394-401.
-
1989: Essig J; Belz G G; Wellstein A
The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
British journal of clinical pharmacology 1989;27 Suppl 2():217S-223S.
-
1989: Belz G G; Essig J; Erb K; Breithaupt K; Hoogkamer J F; Kneer J; Kleinbloesem C H
Pharmacokinetic and pharmacodynamic interactions between the ACE inhibitor cilazapril and beta-adrenoceptor antagonist propranolol in healthy subjects and in hypertensive patients.
British journal of clinical pharmacology 1989;27 Suppl 2():317S-322S.
-
1989: Kleinbloesem C H; Erb K; Essig J; Breithaupt K; Belz G G
Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
British journal of clinical pharmacology 1989;27 Suppl 2():309S-315S.
-
1988: Belz G G; Essig J; Kleinbloesem C H; Hoogkamer J F; Wiegand U W; Wellstein A
Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.
British journal of clinical pharmacology 1988;26(5):547-56.
-
1988: Wellstein A; Belz G G; Palm D
Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots.
The Journal of pharmacology and experimental therapeutics 1988;246(1):328-37.
-
1988: Belz G G; Meinicke T; Schäfer-Korting M
The relationship between pharmacokinetics and pharmacodynamics of enoximone in healthy man.
European journal of clinical pharmacology 1988;35(6):631-5.
-
1987: Schäfer-Korting M; Belz G G; Brauer J; Alken R G; Mutschler E
Digoxin concentrations in serum and cantharides blister fluid: correlations with cardiac response.
Clinical pharmacology and therapeutics 1987;42(6):613-20.
-
1987: Wellstein A; Palm D; Belz G G; Butzer R; Polsak R; Pett B
Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
European heart journal 1987;8 Suppl M():3-8.
-
1987: Wellstein A; Essig J; Belz G G
A method for estimating the potency of angiotensin-converting enzyme inhibitors in man.
British journal of clinical pharmacology 1987;24(3):397-9.
-
1987: Wellstein A; Essig J; Belz G G
Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteers.
Clinical pharmacology and therapeutics 1987;41(6):639-44.
-
1987: Belz G G; Essig J; Wellstein A
Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazapril.
Journal of cardiovascular pharmacology 1987;9(2):219-24.
-
1986: Haegele K D; Belz G G; Meinicke T T; Schechter P J
Pharmacokinetics of piroximone (MDL 19.205) in healthy volunteers.
European journal of clinical pharmacology 1986;31(2):239-42.
-
1984: Alken R G; Belz G G; Haegele K D; Meinicke T; Schechter P J
Kinetics of fenoximone, a new cardiotonic, in healthy subjects.
Clinical pharmacology and therapeutics 1984;36(2):209-16.
Sign-in to see more